The Clorox Company (NYSE:CLX) Shares Acquired by Sowell Financial Services LLC

Sowell Financial Services LLC increased its stake in The Clorox Company (NYSE:CLX) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,078 shares of the company’s stock after acquiring an additional 1,245 shares during the period. Sowell Financial Services LLC’s holdings in Clorox were worth $3,423,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. Integral Investment Advisors Inc. raised its stake in shares of Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock valued at $279,000 after acquiring an additional 67 shares in the last quarter. HCR Wealth Advisors raised its stake in shares of Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after acquiring an additional 68 shares in the last quarter. Empower Advisory Group LLC raised its stake in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after acquiring an additional 78 shares in the last quarter. Aviance Capital Partners LLC increased its holdings in Clorox by 2.7% in the third quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after buying an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC increased its holdings in Clorox by 9.9% in the third quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock valued at $159,000 after buying an additional 88 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE CLX opened at $151.11 on Monday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The business’s 50-day moving average price is $155.65 and its 200 day moving average price is $160.47. The firm has a market cap of $18.61 billion, a P/E ratio of 41.29, a P/E/G ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the company earned $2.16 EPS. On average, equities research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.23%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s dividend payout ratio is currently 133.33%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CLX shares. DA Davidson dropped their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Evercore ISI increased their target price on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays increased their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Wells Fargo & Company increased their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $159.62.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.